CLASS II ONGOING Drug recall · Reported 7 Oct 2026 · FDA Enforcement Report

Focus PI Hypromellose 0.7% Formula, 0.3 FL O per vial, Sterile recalled

Aurolab Trust is recalling Focus PI Hypromellose 0.7% Formula, 0.3 FL O per vial, Sterile, distributed in Virginia. The recall was initiated on 17 Sep 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesBatch# 6B093FI, Exp. 04/01/28; Batch# 6F511F1, Exp. 05/15/28
NDC82724-007
Quantity recalled25,220 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0874-2026
FDA event ID
99903
Recalling firm
Aurolab Trust, Madurai
Manufacturer
COVALENT MEDICAL
Classification
Class II
Status
Ongoing
Recall initiated
17 Sep 2026
FDA classified
28 Sep 2026
Reported
7 Oct 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

17 Sep 2026Recall initiated by company
28 Sep 2026Classified by FDA+11 days
7 Oct 2026Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19

Where it was distributed

VA

Virginia

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility

Which lots are affected?

Batch# 6B093FI, Exp. 04/01/28; Batch# 6F511F1, Exp. 05/15/28

Where was it sold?

VA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 13 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.